价格

二甲双胍维格列汀

Metformin and Vildagliptin

未知生产厂商

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

适应症

配合饮食和运动治疗，用于二甲双胍单药治疗达最大耐受剂量血糖仍控制不住或正在接受维格列汀与二甲双胍联合治疗的成人2型糖尿病患者。

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Formulation
US 2008227825 A1申请人: JOSHI YATINDRA优先权: 2006
US
4 件公开
COMBINATION DRUG FOR THE CONTROL AND MANAGEMENT OF TYPE 2 DIABETES MELLITUS
US 2023310462 A1申请人: LABORATORIOS SILANES S A DE C V优先权: 2020
EP
US
WO
3 件公开
COMBINATION THERAPY WITH VILDAGLIPTIN AND METFORMIN
EP 4335438 A1申请人: NOVARTIS AG优先权: 2019
EP
US
3 件公开
PHARMACEUTICAL COMPOSITION HAVING THE ACTIVE SUBSTANCES METFORMIN AND SITAGLIPTIN OR VILDAGLIPTIN
US 2012202820 A1申请人: RIMKUS KATRIN优先权: 2009
EP
US
2 件公开
A COMBINATION COMPRISING VILDAGLIPTIN AND METFORMIN
EP 4025194 A4申请人: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI优先权: 2019
EP
2 件公开
Pharmaceutical composition containing diabetosan and vildagliptin and preparation thereof
CN 101234105 A申请人: BEIJING RUNDEKANG MEDICAL TECH优先权: 2008
CN
Method for preparing compound preparation containing vildagliptin and metformin hydrochloride
CN 104288144 A申请人: SHANGHAI STEPPHARM CO LTD优先权: 2014
CN
Composition containing vildagliptin and metformin and preparation method of composition
CN 105582008 A申请人: CENTAURUS BIOPHARMA CO LTD优先权: 2014
CN
Medicinal composition containing vildagliptin and metformin hydrochloride
CN 104825446 A申请人: HAIKOU NANLU MEDICINE SCIENCE & TECHNOLOGY CO LTD优先权: 2015
CN
Pharmaceutical composition containing vildagliptin and metformin hydrochloride and preparation method thereof
CN 106551927 A申请人: SHENZHEN HYBIO PHARMACEUTICAL优先权: 2015
CN

药物